ArticleJournal of thrombosis and thrombolysis2017

Effect of the FXa inhibitors Rivaroxaban and Apixaban on platelet activation in patients with atrial fibrillation.

B Steppich et al.PubMed ↗Publisher ↗

No numbers read from the abstract.